Reuters (10/26, Kane) reports Spain has joined
regulatory bodies in Italy and Switzerland in halting the sales of Novartis
AG's flu vaccines, after the company earlier this week, informed Italian
authorities of white particles floating in some of the injection vials. The
Spanish Medicines and Health Products Agency announced Thursday that it has
placed all sales of Novartis's Chiromas and Chiroflu vaccines on hold. On
Wednesday, Italy halted sales and issued an advisory recommending against
purchasing or using Agrippal, Fluad, subunit Influpozzi and adjuvated
Influpozzi until the quality and safety of the vaccines is confirmed.
Switzerland followed suit, issuing a similar consumer notice and placing an
embargo on all deliveries of the vaccine products.
Separately, Reuters (10/26, Burger) reports that the
Paul-Ehrlich Institute on Thursday announced that no buildup of particles was
observed in any of Novartis's vaccine products in Germany. Still, the German
vaccination agency issued what it called a "precautionary" recall of
the company's Begripal and Fluad vaccines.
DIA Daily is a digest of the most important news selected from
thousands of sources by the editors of BulletinHealthcare. The presence of
content or advertising does not endorse, nor imply endorsement of, any products
or services by the Drug Information Association. Neither BulletinHealthcare nor
the Drug Information Association is liable for the use of or reliance on any
information contained in this briefing.
If you would like more information about, or
have a question pertaining to, DIA Membership and its benefits, please email membership@diahome.org.
Click here to check your membership status.
Drug Information
Association | 800 Enterprise Road, Suite 200 | Horsham, PA 19044
Copyright © 2012 by BulletinHealthcare
| 11190 Sunrise Valley Drive, Suite 130 | Reston, VA 20191
No comments:
Post a Comment